Antiarrhythmic drug therapy in congestive heart failure: Indications and complications: Postgraduate Medicine: Vol 90, No 8

Views

CrossRef citations to date

Altmetric

Preview

Should all patients with congestive heart failure and ventricular arrhythmias receive prophylactic antiarrhythmic drug therapy? What are the potential risks of such therapy? Dr Ravid discusses the findings of recent and ongoing studies of antiarrhythmic agents and presents practical guidelines for use of these drugs in patients with heart failure.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Antiarrhythmic drug therapy in congestive heart failure

Indications and complications

Information for

Open access

Opportunities

Help and information

Antiarrhythmic drug therapy in congestive heart failure

Indications and complications

Preview

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date

Your download is now in progress and you may close this window

Login or register to access this feature